Cellebrite Announces Participation in the Morgan Stanley Technology, Media & Telecom Conference

Cellebrite (NASDAQ: CLBT) will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026.

Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026. The company will appear in a 10:45 a.m. ET fireside chat featuring CFO David Barter and VP of Investor Relations Andrew Kramer. Details and a webcast link are available.

Argus Feb 24 session

+5.78% close to close Open Argus

Details

News Market Reaction – CLBT

On Feb 24, the day this news came out, CLBT closed 5.78% above the previous close.

Data tracked by StockTitan Argus for the Feb 24 session.

Key Figures

Conference date: March 3, 2026 Presentation time: 10:45 a.m. ET

Conference date

March 3, 2026

Morgan Stanley Technology, Media & Telecom Conference

Presentation time

10:45 a.m. ET

Scheduled fireside chat session

Historical Context

5 past events · Latest: Feb 11

5 events

1. Feb 11

   Earnings results

   24h Move

   -4.5%

   Record Q4 and FY 2025 results with strong ARR, revenue and guidance.

2. Feb 05

   Industry report

   24h Move

   -2.6%

   2026 trends report showing smartphones and AI as key investigation drivers.

3. Jan 21

   Earnings date set

   24h Move

   -3.9%

   Announcement of timing and access details for Q4 and FY 2025 results.

4. Dec 02

   Acquisition close

   24h Move

   +3.9%

   Closing of $170M Corellium deal to enhance AI-powered investigation platform.

5. Nov 12

   Earnings results

   24h Move

   +1.7%

   Q3 2025 beat with strong ARR, subscription growth and reiterated guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 24, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors,  today announced the Company will participate in the upcoming Morgan Stanley Technology, Media & Telecom Conference. Relevant details include:

Date:	March 3, 2026
Conference:	Morgan Stanley Technology, Media & Telecom Conference
Presentation Time:	10:45 a.m. ET
Format	Fireside Chat
Event URL:	https://investors.cellebrite.com/events/event-details/morgan-stanley-technology-media-telecom-conference
Cellebrite Executives:	David Barter, chief financial officer Andrew Kramer, vice president, investor relations

About Cellebrite
Cellebrite's (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite's AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite's technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com. 

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cellebrite-announces-participation-in-the-morgan-stanley-technology-media--telecom-conference-302695023.html

SOURCE Cellebrite

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Cellebrite (CLBT) present at the Morgan Stanley TMT Conference on March 3, 2026?

Cellebrite will present on March 3, 2026 at 10:45 a.m. ET in a fireside chat. According to Cellebrite, the appearance will feature CFO David Barter and Andrew Kramer from investor relations and is listed on the company events page.

Who from Cellebrite (CLBT) will speak at the Morgan Stanley Technology, Media & Telecom Conference?

Cellebrite will be represented by David Barter, chief financial officer, and Andrew Kramer, vice president investor relations. According to Cellebrite, both executives are scheduled to participate in the March 3, 2026 fireside chat at the conference.

What is the presentation format for Cellebrite (CLBT) at the March 3, 2026 Morgan Stanley conference?

The presentation is a fireside chat scheduled at 10:45 a.m. ET on March 3, 2026. According to Cellebrite, the format is conversational rather than a formal earnings presentation and is listed on the company events page.

Where can investors watch Cellebrite's (CLBT) Morgan Stanley conference presentation on March 3, 2026?

Investors can access event details and the webcast via the company's investor events page. According to Cellebrite, the event URL is provided on its investor relations site for the March 3, 2026 presentation.

Will Cellebrite (CLBT) announce earnings or guidance at the Morgan Stanley TMT Conference on March 3, 2026?

The notice lists a fireside chat and speakers but does not indicate earnings or guidance will be announced. According to Cellebrite, the scheduled appearance is a conference presentation without specified financial disclosures.

How long is the Cellebrite (CLBT) presentation at the Morgan Stanley Technology, Media & Telecom Conference?

The company announced a fireside chat at 10:45 a.m. ET but did not specify duration. According to Cellebrite, only the start time and format are provided on the March 3, 2026 event listing.